BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06483334-completion@plaintrial.com
DTSTAMP:20261028T111645Z
DTSTART;VALUE=DATE:20280331
SUMMARY:A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870)
  Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced U
 rothelial Carcinoma (MK-3475-04C/KEYMAKER-U04) — estimated completion da
 te
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06483334
URL:https://plaintrial.com/trial/NCT06483334
END:VEVENT
END:VCALENDAR